ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,980Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 917

$806K Total Retail Price of All Prescriptions

Rank: 29 out of 917

608 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 608 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 608 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,247 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 485 422 1 3
LISINOPRIL 468 386 2 1
FUROSEMIDE 345 316 3 7
METOPROLOL TARTRATE 334 267 4 11
WARFARIN SODIUM 324 287 5 10
CITALOPRAM HBR 324 267 5 15
LOVAZA 321 261 7 154
SIMVASTATIN 315 254 8 2
FAMOTIDINE 240 226 9 91
METFORMIN HCL 230 184 10 8
GABAPENTIN 223 175 11 17
POTASSIUM CHLORIDE 219 196 12 16
CRESTOR 216 188 13 30
CARVEDILOL 214 187 14 33
AMLODIPINE BESYLATE 207 194 15 5
TRAZODONE HCL 188 142 16 22
ATORVASTATIN CALCIUM 164 148 17 14
TRAMADOL HCL 162 106 18 28
LOSARTAN POTASSIUM 159 121 19 13
HYDROCODONE-ACETAMINOPHEN 152 105 S3 20 6
TAMSULOSIN HCL 145 119 21 25
HYDROCHLOROTHIAZIDE 141 107 22 9
NAMENDA 139 139 23 43
OMEPRAZOLE 138 101 24 4
PRAVASTATIN SODIUM 134 118 25 20
RANITIDINE HCL 116 91 26 29
CYMBALTA 111 79 27 56
PANTOPRAZOLE SODIUM 109 95 28 44
DONEPEZIL HCL 95 95 29 32
PREDNISONE 95 83 29 34
SPIRONOLACTONE 91 80 31 55
RISPERIDONE 86 61 32 51
MIRTAZAPINE 86 76 32 39
KLOR-CON M20 82 78 34 121
OXYCODONE HCL 82 62 S2 34 27
INSULIN SYRINGE 75 32 36 83
ALLOPURINOL 70 60 37 31
NOVOLOG 69 50 38 98
DIOVAN 69 69 38 49
CLOPIDOGREL 67 59 40 50
FENTANYL 66 57 S2 41 58
NIASPAN 66 54 41 157
QUETIAPINE FUMARATE 61 44 43 52
CARBIDOPA-LEVODOPA 59 36 44 86
HYDRALAZINE HCL 59 54 44 90
ZOLPIDEM TARTRATE 58 39 46 21
SERTRALINE HCL 57 37 47 24
AVODART 57 44 47 170
LANTUS 57 43 47 37
ESCITALOPRAM OXALATE 54 36 50 114
AMITRIPTYLINE HCL 54 28 R 50 67
DIGOXIN 54 44 50 41
CYCLOBENZAPRINE HCL 54 28 R 50 65
POLYETHYLENE GLYCOL 3350 53 42 54 66
PAROXETINE HCL 53 51 54 57
PHENYTOIN SODIUM EXTENDED 53 52 54 155
DILTIAZEM ER 53 42 54 106
LEVEMIR 52 36 58 194
MORPHINE SULFATE ER 50 43 S2 59 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.